ranimustine has been researched along with B-Cell Lymphoma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kato, J; Mori, T; Okamoto, S; Shimizu, T; Tsukada, Y; Ueda, T; Yokoyama, K | 1 |
| Aoyama, Y; Hagihara, K; Hino, M; Hirai, M; Hirose, A; Kanashima, H; Koh, KR; Kosaka, S; Kumura, T; Manabe, M; Mugitani, A; Nakajima, Y; Nakamae, M; Nakao, Y; Ohta, K; Sakamoto, C; Sakamoto, E; Terada, Y; Teshima, H; Yamane, T | 1 |
| Iwao, N; Makino, S; Ohsawa, N; Tsujita, Y | 1 |
| Kobayashi, K; Matano, S; Minouchi, K; Ohta, H; Sanada, T; Sugimoto, T | 1 |
4 other study(ies) available for ranimustine and B-Cell Lymphoma
| Article | Year |
|---|---|
Safety and efficacy of high-dose ranimustine, cytarabine, etoposide and CY (MCVAC) regimen followed by autologous peripheral blood stem cell transplantation for high-risk diffuse large B-cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Male; Middle Aged; Nitrosourea Compounds; Survival Analysis; Transplantation Conditioning; Treatment Outcome; Young Adult | 2011 |
[Autologous hematopoietic stem cell transplantation for aggressive B-cell non-Hodgkin's lymphoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Nitrosourea Compounds; Remission Induction; Transplantation, Autologous; Treatment Outcome | 2005 |
[Syndrome of inappropriate secretion of antidiuretic hormone and neurotoxicity induced by vincristine and alkylating agents during chemotherapy for malignant lymphoma of thyroid gland].
Topics: Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Central Nervous System; Cyclophosphamide; Erythema; Humans; Ifosfamide; Inappropriate ADH Syndrome; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Nitrosourea Compounds; Thyroid Neoplasms; Vincristine | 1998 |
Prophylactic effect of interferon-alpha for exacerbation of hepatitis B after high-dose chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cyclophosphamide; DNA, Viral; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Hepatitis B, Chronic; Humans; Interferon-alpha; Liver Function Tests; Lymphoma, B-Cell; Male; Nitrosourea Compounds; Prednisone; Radiotherapy, Adjuvant; Remission Induction; Salvage Therapy; Transplantation, Autologous; Vincristine; Viremia; Virus Activation | 2001 |